Last update 21 Nov 2024

PMG-1015

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
a humanized, immunoglobulin G subtype 4 anti-Amphiregulin monoclonal antibody
Target
AREG
Mechanism
AREG modulators(Amphiregulin ligand modulators), Immunomodulators
Therapeutic Areas
Respiratory DiseasesOther Diseases
Active Indication
Idiopathic Pulmonary Fibrosis
Inactive Indication-
Originator Organization
Pulmongene (Hong Kong) Co., Ltd.
Active Organization
Pulmongene (Hong Kong) Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Related

4
Clinical Trials associated with PMG-1015
NCT05895565 / RecruitingPhase 1
A Phase 1b, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PMG1015 in Idiopathic Pulmonary Fibrosis (IPF) Subjects
CTR20230999 / RecruitingPhase 1
一项评估PMG1015注射液在特发性肺纤维化（IPF）受试者中多次给药、剂量递增的安全性、耐受性和药代动力学的1b期，多中心、随机、双盲、安慰剂对照临床试验
[Translation] A Phase 1b, multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety, tolerability, and pharmacokinetics of multiple-dose, dose-escalating PMG1015 injection in subjects with idiopathic pulmonary fibrosis (IPF)
CTR20221571 / CompletedPhase 1
评估PMG1015注射液在健康志愿者中的安全性、耐受性、药代动力学和免疫原性的、随机、双盲、安慰剂对照、单剂量递增的Ia期研究
[Translation] A randomized, double-blind, placebo-controlled, single-ascending dose Phase Ia study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of PMG1015 injection in healthy volunteers
100 Clinical Results associated with PMG-1015
Login to view more data
100 Translational Medicine associated with PMG-1015
Login to view more data
100 Patents (Medical) associated with PMG-1015
Login to view more data
100 Deals associated with PMG-1015
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Idiopathic Pulmonary FibrosisDiscovery
AU
Pulmongene (Hong Kong) Co., Ltd.
14 Oct 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free